RETIFANLIMAB-DLWR

RETIFANLIMAB-DLWR was reported 72 times

RETIFANLIMAB-DLWR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANAL CANCER RECURRENT 1 0.0476
1 ANAL SQUAMOUS CELL CARCINOMA 6 0.0195
2 COLOSTOMY INFECTION 1 0.0167
3 ANAL CANCER 5 0.0052
4 NEUROENDOCRINE CARCINOMA OF THE SKIN 1 0.0010
5 SECONDARY ADRENOCORTICAL INSUFFICIENCY 1 0.0007
6 INFUSION SITE INFECTION 1 0.0004
7 JOINT LOCK 1 0.0004
8 THYROIDITIS 1 0.0003
9 AUTOIMMUNE THYROIDITIS 1 0.0003
10 PLATELET COUNT ABNORMAL 1 0.0002
11 METASTASES TO LIVER 2 0.0001
12 DISEASE PROGRESSION 11 0.0001
13 ELECTROLYTE IMBALANCE 1 0.0001
14 COVID-19 PNEUMONIA 1 0.0001
15 POLYNEUROPATHY 1 0.0001
16 HYPERTHYROIDISM 1 0.0001
17 HYPOAESTHESIA ORAL 1 0.0001
18 DRUG ERUPTION 1 0.0001
19 INTESTINAL OBSTRUCTION 2 0.0001
20 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
21 THERAPY CESSATION 2 0.0000
22 SKIN ULCER 1 0.0000
23 TREATMENT NONCOMPLIANCE 2 0.0000
24 DYSSTASIA 1 0.0000
25 PSYCHOTIC DISORDER 1 0.0000
26 NEUROPATHY PERIPHERAL 3 0.0000
27 OFF LABEL USE 25 0.0000
28 THROMBOCYTOPENIA 3 0.0000
29 BLINDNESS 1 0.0000
30 HYPOGLYCAEMIA 1 0.0000
31 CELLULITIS 1 0.0000
32 PLATELET COUNT DECREASED 2 0.0000
33 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
34 BONE PAIN 1 0.0000
35 ANAEMIA 3 0.0000
36 INFUSION RELATED REACTION 1 0.0000
37 NEUTROPENIA 2 0.0000
38 HEPATIC ENZYME INCREASED 1 0.0000
39 MOBILITY DECREASED 1 0.0000
40 DIABETES MELLITUS 1 0.0000
41 DECREASED APPETITE 3 0.0000
42 PRODUCT STORAGE ERROR 1 0.0000
43 GASTROINTESTINAL DISORDER 1 0.0000
44 NASOPHARYNGITIS 2 0.0000
45 BREAST CANCER 1 0.0000
46 PRODUCT DOSE OMISSION ISSUE 3 0.0000
47 CONDITION AGGRAVATED 3 0.0000
48 ILLNESS 1 0.0000
49 OEDEMA PERIPHERAL 1 0.0000
50 PSORIASIS 1 0.0000
51 MALAISE 3 0.0000
52 HYPOAESTHESIA 1 0.0000
53 HOSPITALISATION 1 0.0000
54 URTICARIA 1 0.0000
55 URINARY TRACT INFECTION 1 0.0000
56 COVID-19 1 0.0000
57 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
58 NO ADVERSE EVENT 1 0.0000
59 HYPERSENSITIVITY 1 0.0000
60 GAIT DISTURBANCE 1 0.0000
61 ALOPECIA 1 0.0000
62 NAUSEA 4 0.0000
63 DEATH 4 0.0000
64 DEPRESSION 1 0.0000
65 FEELING ABNORMAL 1 0.0000
66 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
67 WEIGHT DECREASED 1 0.0000
68 ASTHENIA 1 0.0000
69 ARTHRALGIA 1 0.0000
70 VOMITING 1 0.0000
71 DIARRHOEA 1 0.0000
72 FATIGUE 1 0.0000